Medical News

RSS

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

A recent study investigated the potency and functionality of T-cell and humoral responses against the SARS-CoV-2 wild-type strain and its variants.

28 Mar 2022

Study investigates recombinant SARS-CoV-2 variants in immunocompromised individuals

Researchers identified the recombination of two SARS-CoV-2 variants.

28 Mar 2022

Study estimates protection against reinfection following primary SARS-CoV-2 infection

A recent study investigated the protection provided by the primary SARS-CoV-2 infection against reinfection.

28 Mar 2022

‘An Arm and a Leg’: A fight for the right to help

Americans get sued over medical debt. A lot. And — no surprise — many folks getting sued can't afford lawyers.

28 Mar 2022

Climate change may push the US toward the ‘goldilocks zone’ for West Nile virus

Michael Keasling of Lakewood, Colorado, was an electrician who loved big trucks, fast cars, and Harley-Davidsons. He'd struggled with diabetes since he was a teenager, needing a kidney transplant from his sister to stay alive.

28 Mar 2022

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Sen. Tim Scott, a rising star in the Republican Party with broad popularity in his home state of South Carolina, is getting showered with drug industry money before facing voters this fall.

28 Mar 2022

Benefits of heterotypic vaccination against variants of SARS-CoV-2

A new study evaluated the antibody responses against the newly emerged SARS-CoV-2 Omicron variant upon heterotypic vaccination in animal models.

28 Mar 2022

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Researchers designed a dynamic mathematical model to simulate the transmission of the SARS-CoV-2 Omicron variant in China and project its associated burden on healthcare facilities, should the zero-COVID-19 policy be lifted.

28 Mar 2022

Study evaluates receptor-binding domain antibodies for their ability to bind and neutralize Omicron

Researchers evaluated the ability of RBD antibodies to bind to and neutralize SARS-CoV-2 Omicron variant.

28 Mar 2022

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

A recent study investigated the disease severity of SARS-CoV-2 Omicron BA.2 infection among Hong Kong children.

28 Mar 2022

How malaria drugs could play a part in treating chemotherapy-resistant head and neck cancers

In this interview, we speak to Kirill Kiselyov, Ph.D, and Umamaheswar Duvvuri, M.D, Ph.D, from the University of Pittsburgh, about their latest research into hydroxychloroquine, a drug widely used to prevent and treat malaria, as a potential treatment for head and neck cancers.

28 Mar 2022

Study finds fewer hospital visits for stroke in first year of COVID-19 pandemic

The first year of the COVID-19 pandemic saw fewer hospital visits for stroke, fewer stroke therapies, more treatment delays and a higher risk of in-hospital deaths in the subsequent COVID-19 waves, according to an Alberta study published in CMAJ.

28 Mar 2022

Which U.S. cities are most vulnerable to spread of COVID-19?

Now, researchers from New Jersey City University have been attempting to explore the same factors to identify vulnerability in U.S. cities. Their research, under consideration at the journal Scientific Reports, is currently available on the Research Square* preprint server.

28 Mar 2022

Frequent population screening can effectively reduce the transmission of SARS-CoV-2

In the face of the escalating fifth wave outbreak in Hong Kong, the government is planning a universal population screening that will combine antigen tests and PCR tests.

27 Mar 2022

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

A new research paper published as an early release manuscript in the Nature Medicine journal compares the sensitivity of this strain as well as the earlier Delta and the newer BA.2 to therapeutic mAbs.

27 Mar 2022

The effects of severe COVID-19 on the lungs after one year

While short-term lung damage has been reported in patients hospitalized with pneumonia caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is little data on the more chronic sequelae of this condition. A new research paper summarizes data from patients seen one year from discharge.

27 Mar 2022

Medical News

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Study investigates recombinant SARS-CoV-2 variants in immunocompromised individuals

Study estimates protection against reinfection following primary SARS-CoV-2 infection

‘An Arm and a Leg’: A fight for the right to help

Climate change may push the US toward the ‘goldilocks zone’ for West Nile virus

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Benefits of heterotypic vaccination against variants of SARS-CoV-2

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Study evaluates receptor-binding domain antibodies for their ability to bind and neutralize Omicron

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

How malaria drugs could play a part in treating chemotherapy-resistant head and neck cancers

Study finds fewer hospital visits for stroke in first year of COVID-19 pandemic

Which U.S. cities are most vulnerable to spread of COVID-19?

Frequent population screening can effectively reduce the transmission of SARS-CoV-2

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

The effects of severe COVID-19 on the lungs after one year

Tuberculosis infection protects mice against COVID-19

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

CDK6: a potential drug target for severe COVID-19

Clinical determinants of post-COVID-19 thromboembolism

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News